table of content
1 Introduction to Research & Analysis Reports
1.1 Women?s Health Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Women?s Health Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Women?s Health Drugs Overall Market Size
2.1 Global Women?s Health Drugs Market Size: 2022 VS 2030
2.2 Global Women?s Health Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Women?s Health Drugs Players in Global Market
3.2 Top Global Women?s Health Drugs Companies Ranked by Revenue
3.3 Global Women?s Health Drugs Revenue by Companies
3.4 Top 3 and Top 5 Women?s Health Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Women?s Health Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Women?s Health Drugs Players in Global Market
3.6.1 List of Global Tier 1 Women?s Health Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Women?s Health Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Women?s Health Drugs Market Size Markets, 2022 & 2030
4.1.2 EVISTA
4.1.3 XGEVA
4.1.4 Prolia
4.1.5 Mirena
4.1.6 Zometa
4.1.7 Reclast/Aclasta
4.1.8 Minastrin 24 Fe
4.1.9 Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
4.2 By Type - Global Women?s Health Drugs Revenue & Forecasts
4.2.1 By Type - Global Women?s Health Drugs Revenue, 2018-2023
4.2.2 By Type - Global Women?s Health Drugs Revenue, 2024-2030
4.2.3 By Type - Global Women?s Health Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Women?s Health Drugs Market Size, 2022 & 2030
5.1.2 Hormonal Infertility
5.1.3 Postmenopausal Osteoporosis
5.1.4 Endometriosis
5.1.5 Contraceptives
5.1.6 Menopause
5.1.7 Polycystic Ovary Syndrome
5.1.8 Other Applications
5.2 By Application - Global Women?s Health Drugs Revenue & Forecasts
5.2.1 By Application - Global Women?s Health Drugs Revenue, 2018-2023
5.2.2 By Application - Global Women?s Health Drugs Revenue, 2024-2030
5.2.3 By Application - Global Women?s Health Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Women?s Health Drugs Market Size, 2022 & 2030
6.2 By Region - Global Women?s Health Drugs Revenue & Forecasts
6.2.1 By Region - Global Women?s Health Drugs Revenue, 2018-2023
6.2.2 By Region - Global Women?s Health Drugs Revenue, 2024-2030
6.2.3 By Region - Global Women?s Health Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Women?s Health Drugs Revenue, 2018-2030
6.3.2 US Women?s Health Drugs Market Size, 2018-2030
6.3.3 Canada Women?s Health Drugs Market Size, 2018-2030
6.3.4 Mexico Women?s Health Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Women?s Health Drugs Revenue, 2018-2030
6.4.2 Germany Women?s Health Drugs Market Size, 2018-2030
6.4.3 France Women?s Health Drugs Market Size, 2018-2030
6.4.4 U.K. Women?s Health Drugs Market Size, 2018-2030
6.4.5 Italy Women?s Health Drugs Market Size, 2018-2030
6.4.6 Russia Women?s Health Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Women?s Health Drugs Market Size, 2018-2030
6.4.8 Benelux Women?s Health Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Women?s Health Drugs Revenue, 2018-2030
6.5.2 China Women?s Health Drugs Market Size, 2018-2030
6.5.3 Japan Women?s Health Drugs Market Size, 2018-2030
6.5.4 South Korea Women?s Health Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Women?s Health Drugs Market Size, 2018-2030
6.5.6 India Women?s Health Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Women?s Health Drugs Revenue, 2018-2030
6.6.2 Brazil Women?s Health Drugs Market Size, 2018-2030
6.6.3 Argentina Women?s Health Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Women?s Health Drugs Revenue, 2018-2030
6.7.2 Turkey Women?s Health Drugs Market Size, 2018-2030
6.7.3 Israel Women?s Health Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Women?s Health Drugs Market Size, 2018-2030
6.7.5 UAE Women?s Health Drugs Market Size, 2018-2030
7 Women?s Health Drugs Companies Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Women?s Health Drugs Major Product Offerings
7.1.4 Bayer AG Women?s Health Drugs Revenue in Global Market (2018-2023)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Women?s Health Drugs Major Product Offerings
7.2.4 Allergan Women?s Health Drugs Revenue in Global Market (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 Merck & Co
7.3.1 Merck & Co Company Summary
7.3.2 Merck & Co Business Overview
7.3.3 Merck & Co Women?s Health Drugs Major Product Offerings
7.3.4 Merck & Co Women?s Health Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck & Co Key News & Latest Developments
7.4 Pfizer Inc
7.4.1 Pfizer Inc Company Summary
7.4.2 Pfizer Inc Business Overview
7.4.3 Pfizer Inc Women?s Health Drugs Major Product Offerings
7.4.4 Pfizer Inc Women?s Health Drugs Revenue in Global Market (2018-2023)
7.4.5 Pfizer Inc Key News & Latest Developments
7.5 Amgen
7.5.1 Amgen Company Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Women?s Health Drugs Major Product Offerings
7.5.4 Amgen Women?s Health Drugs Revenue in Global Market (2018-2023)
7.5.5 Amgen Key News & Latest Developments
7.6 Agile Therapeutics Inc
7.6.1 Agile Therapeutics Inc Company Summary
7.6.2 Agile Therapeutics Inc Business Overview
7.6.3 Agile Therapeutics Inc Women?s Health Drugs Major Product Offerings
7.6.4 Agile Therapeutics Inc Women?s Health Drugs Revenue in Global Market (2018-2023)
7.6.5 Agile Therapeutics Inc Key News & Latest Developments
7.7 Ferring Pharmaceuticals
7.7.1 Ferring Pharmaceuticals Company Summary
7.7.2 Ferring Pharmaceuticals Business Overview
7.7.3 Ferring Pharmaceuticals Women?s Health Drugs Major Product Offerings
7.7.4 Ferring Pharmaceuticals Women?s Health Drugs Revenue in Global Market (2018-2023)
7.7.5 Ferring Pharmaceuticals Key News & Latest Developments
7.8 Mylan N.V.
7.8.1 Mylan N.V. Company Summary
7.8.2 Mylan N.V. Business Overview
7.8.3 Mylan N.V. Women?s Health Drugs Major Product Offerings
7.8.4 Mylan N.V. Women?s Health Drugs Revenue in Global Market (2018-2023)
7.8.5 Mylan N.V. Key News & Latest Developments
7.9 Lupin (India)
7.9.1 Lupin (India) Company Summary
7.9.2 Lupin (India) Business Overview
7.9.3 Lupin (India) Women?s Health Drugs Major Product Offerings
7.9.4 Lupin (India) Women?s Health Drugs Revenue in Global Market (2018-2023)
7.9.5 Lupin (India) Key News & Latest Developments
7.10 Eli Lilly And Company
7.10.1 Eli Lilly And Company Company Summary
7.10.2 Eli Lilly And Company Business Overview
7.10.3 Eli Lilly And Company Women?s Health Drugs Major Product Offerings
7.10.4 Eli Lilly And Company Women?s Health Drugs Revenue in Global Market (2018-2023)
7.10.5 Eli Lilly And Company Key News & Latest Developments
7.11 Novartis AG
7.11.1 Novartis AG Company Summary
7.11.2 Novartis AG Business Overview
7.11.3 Novartis AG Women?s Health Drugs Major Product Offerings
7.11.4 Novartis AG Women?s Health Drugs Revenue in Global Market (2018-2023)
7.11.5 Novartis AG Key News & Latest Developments
7.12 Johnson & Johnson
7.12.1 Johnson & Johnson Company Summary
7.12.2 Johnson & Johnson Business Overview
7.12.3 Johnson & Johnson Women?s Health Drugs Major Product Offerings
7.12.4 Johnson & Johnson Women?s Health Drugs Revenue in Global Market (2018-2023)
7.12.5 Johnson & Johnson Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
